Aminolevulinic Acid (ALA) as a Prodrug in Photodynamic Therapy of Cancer
Aminolevulinic acid (ALA) is an endogenous metabolite normally formed in the mitochondria from succinyl-CoA and glycine. Conjugation of eight ALA molecules yields protoporphyrin IX (PpIX) and finally leads to formation of heme. Conversion of PpIX to its downstream substrates requires the activity of...
Main Authors: | Jakub Golab, Kamil Bojarczuk, Małgorzata Wańczyk, Magdalena Winiarska, Magdalena Gabrysiak, Małgorzata Firczuk, Angelika Muchowicz, Małgorzata Wachowska |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2011-05-01
|
Series: | Molecules |
Subjects: | |
Online Access: | http://www.mdpi.com/1420-3049/16/5/4140/ |
Similar Items
-
Inhibition of autophagy sensitizes cancer cells to Photofrin-based photodynamic therapy
by: Antoni Domagala, et al.
Published: (2018-02-01) -
Amplifying the efficacy of ALA-based prodrugs for photodynamic therapy using nanotechnology
by: Liang Lou, et al.
Published: (2023-02-01) -
The use of 5-aminolevulinic acid and its derivatives in photodynamic therapy and diagnosis
by: Anna Romiszewska, et al.
Published: (2018-12-01) -
Targeting epigenetic processes in photodynamic therapy-induced anticancer immunity
by: Malgorzata eWachowska, et al.
Published: (2015-07-01) -
Photodynamic Detection of Peritoneal Metastases Using 5-Aminolevulinic Acid (ALA)
by: Yutaka Yonemura, et al.
Published: (2017-03-01)